nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CUBN—nephron—kidney cancer	0.0374	0.163	CbGeAlD
Hydroxocobalamin—AMN—nephron tubule—kidney cancer	0.00959	0.0419	CbGeAlD
Hydroxocobalamin—AMN—renal system—kidney cancer	0.00871	0.0381	CbGeAlD
Hydroxocobalamin—AMN—kidney—kidney cancer	0.00843	0.0369	CbGeAlD
Hydroxocobalamin—AMN—cortex of kidney—kidney cancer	0.00821	0.0359	CbGeAlD
Hydroxocobalamin—CUBN—nephron tubule—kidney cancer	0.00807	0.0353	CbGeAlD
Hydroxocobalamin—CUBN—renal system—kidney cancer	0.00734	0.0321	CbGeAlD
Hydroxocobalamin—CUBN—kidney—kidney cancer	0.00709	0.031	CbGeAlD
Hydroxocobalamin—CUBN—cortex of kidney—kidney cancer	0.00691	0.0302	CbGeAlD
Hydroxocobalamin—CASP9—nephron tubule—kidney cancer	0.00669	0.0292	CbGeAlD
Hydroxocobalamin—TCN2—nephron tubule—kidney cancer	0.00653	0.0285	CbGeAlD
Hydroxocobalamin—MMAB—cortex of kidney—kidney cancer	0.00613	0.0268	CbGeAlD
Hydroxocobalamin—CASP9—renal system—kidney cancer	0.00608	0.0266	CbGeAlD
Hydroxocobalamin—TCN2—renal system—kidney cancer	0.00593	0.0259	CbGeAlD
Hydroxocobalamin—CASP9—kidney—kidney cancer	0.00588	0.0257	CbGeAlD
Hydroxocobalamin—TCN2—kidney—kidney cancer	0.00574	0.0251	CbGeAlD
Hydroxocobalamin—CASP9—cortex of kidney—kidney cancer	0.00572	0.025	CbGeAlD
Hydroxocobalamin—TCN2—cortex of kidney—kidney cancer	0.00559	0.0244	CbGeAlD
Hydroxocobalamin—MUT—nephron tubule—kidney cancer	0.00513	0.0224	CbGeAlD
Hydroxocobalamin—MUT—renal system—kidney cancer	0.00467	0.0204	CbGeAlD
Hydroxocobalamin—MTRR—nephron tubule—kidney cancer	0.00461	0.0202	CbGeAlD
Hydroxocobalamin—MUT—kidney—kidney cancer	0.00451	0.0197	CbGeAlD
Hydroxocobalamin—MUT—cortex of kidney—kidney cancer	0.00439	0.0192	CbGeAlD
Hydroxocobalamin—MTRR—renal system—kidney cancer	0.00419	0.0183	CbGeAlD
Hydroxocobalamin—MUT—gonad—kidney cancer	0.00418	0.0183	CbGeAlD
Hydroxocobalamin—MUT—cardiac atrium—kidney cancer	0.00418	0.0183	CbGeAlD
Hydroxocobalamin—MTRR—kidney—kidney cancer	0.00405	0.0177	CbGeAlD
Hydroxocobalamin—MTR—nephron tubule—kidney cancer	0.00402	0.0176	CbGeAlD
Hydroxocobalamin—MTRR—cortex of kidney—kidney cancer	0.00395	0.0173	CbGeAlD
Hydroxocobalamin—MTRR—gonad—kidney cancer	0.00376	0.0164	CbGeAlD
Hydroxocobalamin—MTRR—cardiac atrium—kidney cancer	0.00375	0.0164	CbGeAlD
Hydroxocobalamin—MTR—renal system—kidney cancer	0.00366	0.016	CbGeAlD
Hydroxocobalamin—MTR—kidney—kidney cancer	0.00353	0.0155	CbGeAlD
Hydroxocobalamin—MTR—cortex of kidney—kidney cancer	0.00344	0.0151	CbGeAlD
Hydroxocobalamin—MTR—gonad—kidney cancer	0.00328	0.0143	CbGeAlD
Hydroxocobalamin—MTR—cardiac atrium—kidney cancer	0.00327	0.0143	CbGeAlD
Hydroxocobalamin—Immune system disorder—Gemcitabine—kidney cancer	0.000544	0.0014	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Sorafenib—kidney cancer	0.000544	0.00139	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Gemcitabine—kidney cancer	0.000543	0.00139	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Erlotinib—kidney cancer	0.000543	0.00139	CcSEcCtD
Hydroxocobalamin—Rash—Temsirolimus—kidney cancer	0.000542	0.00139	CcSEcCtD
Hydroxocobalamin—Dermatitis—Temsirolimus—kidney cancer	0.000541	0.00139	CcSEcCtD
Hydroxocobalamin—Chills—Gemcitabine—kidney cancer	0.000541	0.00139	CcSEcCtD
Hydroxocobalamin—Skin disorder—Sorafenib—kidney cancer	0.000539	0.00138	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Gemcitabine—kidney cancer	0.000538	0.00138	CcSEcCtD
Hydroxocobalamin—Headache—Temsirolimus—kidney cancer	0.000538	0.00138	CcSEcCtD
Hydroxocobalamin—Dizziness—Pazopanib—kidney cancer	0.000535	0.00137	CcSEcCtD
Hydroxocobalamin—Oedema—Sunitinib—kidney cancer	0.000534	0.00137	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000532	0.00136	CcSEcCtD
Hydroxocobalamin—Infection—Sunitinib—kidney cancer	0.00053	0.00136	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Vinblastine—kidney cancer	0.000529	0.00136	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Doxorubicin—kidney cancer	0.000528	0.00136	CcSEcCtD
Hydroxocobalamin—Pain—Erlotinib—kidney cancer	0.000527	0.00135	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Everolimus—kidney cancer	0.000526	0.00135	CcSEcCtD
Hydroxocobalamin—Erythema—Gemcitabine—kidney cancer	0.000525	0.00135	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Sunitinib—kidney cancer	0.000523	0.00134	CcSEcCtD
Hydroxocobalamin—Discomfort—Dactinomycin—kidney cancer	0.000521	0.00134	CcSEcCtD
Hydroxocobalamin—Skin disorder—Sunitinib—kidney cancer	0.000518	0.00133	CcSEcCtD
Hydroxocobalamin—Dysphagia—Capecitabine—kidney cancer	0.000517	0.00133	CcSEcCtD
Hydroxocobalamin—Rash—Pazopanib—kidney cancer	0.00051	0.00131	CcSEcCtD
Hydroxocobalamin—Nausea—Temsirolimus—kidney cancer	0.00051	0.00131	CcSEcCtD
Hydroxocobalamin—Dermatitis—Pazopanib—kidney cancer	0.00051	0.00131	CcSEcCtD
Hydroxocobalamin—Agitation—Vincristine—kidney cancer	0.000508	0.0013	CcSEcCtD
Hydroxocobalamin—Headache—Pazopanib—kidney cancer	0.000507	0.0013	CcSEcCtD
Hydroxocobalamin—Oedema—Dactinomycin—kidney cancer	0.000505	0.0013	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Everolimus—kidney cancer	0.000505	0.0013	CcSEcCtD
Hydroxocobalamin—Infection—Dactinomycin—kidney cancer	0.000502	0.00129	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Paclitaxel—kidney cancer	0.000498	0.00128	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Paclitaxel—kidney cancer	0.000497	0.00127	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Capecitabine—kidney cancer	0.000496	0.00127	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Paclitaxel—kidney cancer	0.000495	0.00127	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Sorafenib—kidney cancer	0.000494	0.00127	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Sorafenib—kidney cancer	0.000488	0.00125	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Erlotinib—kidney cancer	0.000487	0.00125	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Gemcitabine—kidney cancer	0.000487	0.00125	CcSEcCtD
Hydroxocobalamin—Nausea—Pazopanib—kidney cancer	0.000481	0.00123	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000479	0.00123	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Sunitinib—kidney cancer	0.000476	0.00122	CcSEcCtD
Hydroxocobalamin—Pain—Sorafenib—kidney cancer	0.000474	0.00122	CcSEcCtD
Hydroxocobalamin—Malaise—Gemcitabine—kidney cancer	0.000473	0.00121	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—kidney cancer	0.000473	0.00121	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vinblastine—kidney cancer	0.000473	0.00121	CcSEcCtD
Hydroxocobalamin—Eye disorder—Paclitaxel—kidney cancer	0.000472	0.00121	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Everolimus—kidney cancer	0.000471	0.00121	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Sunitinib—kidney cancer	0.00047	0.0012	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Paclitaxel—kidney cancer	0.000468	0.0012	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000461	0.00118	CcSEcCtD
Hydroxocobalamin—Angiopathy—Paclitaxel—kidney cancer	0.000458	0.00117	CcSEcCtD
Hydroxocobalamin—Pain—Sunitinib—kidney cancer	0.000456	0.00117	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Paclitaxel—kidney cancer	0.000456	0.00117	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Paclitaxel—kidney cancer	0.000455	0.00117	CcSEcCtD
Hydroxocobalamin—Chills—Paclitaxel—kidney cancer	0.000453	0.00116	CcSEcCtD
Hydroxocobalamin—Pruritus—Everolimus—kidney cancer	0.000452	0.00116	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Vincristine—kidney cancer	0.000451	0.00116	CcSEcCtD
Hydroxocobalamin—Oedema—Vincristine—kidney cancer	0.000451	0.00116	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Paclitaxel—kidney cancer	0.000451	0.00116	CcSEcCtD
Hydroxocobalamin—Infection—Vincristine—kidney cancer	0.000448	0.00115	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—kidney cancer	0.000448	0.00115	CcSEcCtD
Hydroxocobalamin—Chest pain—Gemcitabine—kidney cancer	0.000447	0.00115	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000444	0.00114	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Vincristine—kidney cancer	0.000443	0.00114	CcSEcCtD
Hydroxocobalamin—Mental disorder—Paclitaxel—kidney cancer	0.000442	0.00113	CcSEcCtD
Hydroxocobalamin—Discomfort—Gemcitabine—kidney cancer	0.000441	0.00113	CcSEcCtD
Hydroxocobalamin—Urticaria—Sorafenib—kidney cancer	0.000441	0.00113	CcSEcCtD
Hydroxocobalamin—Erythema—Paclitaxel—kidney cancer	0.000439	0.00113	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vinblastine—kidney cancer	0.000439	0.00113	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Sorafenib—kidney cancer	0.000438	0.00112	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Everolimus—kidney cancer	0.000437	0.00112	CcSEcCtD
Hydroxocobalamin—Pruritus—Erlotinib—kidney cancer	0.000436	0.00112	CcSEcCtD
Hydroxocobalamin—Pain—Dactinomycin—kidney cancer	0.000432	0.00111	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—kidney cancer	0.000429	0.0011	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000428	0.0011	CcSEcCtD
Hydroxocobalamin—Oedema—Gemcitabine—kidney cancer	0.000428	0.0011	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000425	0.00109	CcSEcCtD
Hydroxocobalamin—Infection—Gemcitabine—kidney cancer	0.000425	0.00109	CcSEcCtD
Hydroxocobalamin—Dizziness—Vinblastine—kidney cancer	0.000424	0.00109	CcSEcCtD
Hydroxocobalamin—Dizziness—Everolimus—kidney cancer	0.000422	0.00108	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Sunitinib—kidney cancer	0.000422	0.00108	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Erlotinib—kidney cancer	0.000422	0.00108	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Gemcitabine—kidney cancer	0.00042	0.00108	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dactinomycin—kidney cancer	0.000416	0.00107	CcSEcCtD
Hydroxocobalamin—Skin disorder—Gemcitabine—kidney cancer	0.000416	0.00107	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—kidney cancer	0.000412	0.00106	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Capecitabine—kidney cancer	0.000409	0.00105	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—kidney cancer	0.000409	0.00105	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Sorafenib—kidney cancer	0.000409	0.00105	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Capecitabine—kidney cancer	0.000408	0.00105	CcSEcCtD
Hydroxocobalamin—Dizziness—Erlotinib—kidney cancer	0.000408	0.00105	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Paclitaxel—kidney cancer	0.000408	0.00105	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Capecitabine—kidney cancer	0.000406	0.00104	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—kidney cancer	0.000404	0.00104	CcSEcCtD
Hydroxocobalamin—Agitation—Paclitaxel—kidney cancer	0.000404	0.00104	CcSEcCtD
Hydroxocobalamin—Rash—Everolimus—kidney cancer	0.000403	0.00103	CcSEcCtD
Hydroxocobalamin—Dermatitis—Everolimus—kidney cancer	0.000402	0.00103	CcSEcCtD
Hydroxocobalamin—Headache—Vinblastine—kidney cancer	0.000402	0.00103	CcSEcCtD
Hydroxocobalamin—Angioedema—Paclitaxel—kidney cancer	0.000401	0.00103	CcSEcCtD
Hydroxocobalamin—Headache—Everolimus—kidney cancer	0.0004	0.00103	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dactinomycin—kidney cancer	0.000399	0.00102	CcSEcCtD
Hydroxocobalamin—Malaise—Paclitaxel—kidney cancer	0.000396	0.00102	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Sunitinib—kidney cancer	0.000393	0.00101	CcSEcCtD
Hydroxocobalamin—Pruritus—Sorafenib—kidney cancer	0.000392	0.00101	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Vincristine—kidney cancer	0.00039	0.000999	CcSEcCtD
Hydroxocobalamin—Rash—Erlotinib—kidney cancer	0.000389	0.000997	CcSEcCtD
Hydroxocobalamin—Dermatitis—Erlotinib—kidney cancer	0.000388	0.000996	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—kidney cancer	0.000387	0.000994	CcSEcCtD
Hydroxocobalamin—Eye disorder—Capecitabine—kidney cancer	0.000387	0.000992	CcSEcCtD
Hydroxocobalamin—Headache—Erlotinib—kidney cancer	0.000386	0.00099	CcSEcCtD
Hydroxocobalamin—Pain—Vincristine—kidney cancer	0.000386	0.00099	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Capecitabine—kidney cancer	0.000384	0.000986	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Gemcitabine—kidney cancer	0.000382	0.000979	CcSEcCtD
Hydroxocobalamin—Nausea—Vinblastine—kidney cancer	0.000381	0.000977	CcSEcCtD
Hydroxocobalamin—Nausea—Everolimus—kidney cancer	0.000379	0.000973	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Sorafenib—kidney cancer	0.000379	0.000973	CcSEcCtD
Hydroxocobalamin—Pruritus—Sunitinib—kidney cancer	0.000378	0.000968	CcSEcCtD
Hydroxocobalamin—Angiopathy—Capecitabine—kidney cancer	0.000376	0.000964	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Capecitabine—kidney cancer	0.000374	0.000959	CcSEcCtD
Hydroxocobalamin—Chest pain—Paclitaxel—kidney cancer	0.000374	0.000959	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Capecitabine—kidney cancer	0.000373	0.000957	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Dactinomycin—kidney cancer	0.000372	0.000955	CcSEcCtD
Hydroxocobalamin—Chills—Capecitabine—kidney cancer	0.000372	0.000953	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000371	0.000952	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Capecitabine—kidney cancer	0.00037	0.000949	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00037	0.000948	CcSEcCtD
Hydroxocobalamin—Discomfort—Paclitaxel—kidney cancer	0.000369	0.000948	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—kidney cancer	0.000367	0.000941	CcSEcCtD
Hydroxocobalamin—Dizziness—Sorafenib—kidney cancer	0.000367	0.000941	CcSEcCtD
Hydroxocobalamin—Pain—Gemcitabine—kidney cancer	0.000366	0.000939	CcSEcCtD
Hydroxocobalamin—Nausea—Erlotinib—kidney cancer	0.000366	0.000939	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Sunitinib—kidney cancer	0.000365	0.000936	CcSEcCtD
Hydroxocobalamin—Mental disorder—Capecitabine—kidney cancer	0.000363	0.00093	CcSEcCtD
Hydroxocobalamin—Erythema—Capecitabine—kidney cancer	0.00036	0.000924	CcSEcCtD
Hydroxocobalamin—Oedema—Paclitaxel—kidney cancer	0.000358	0.000919	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000358	0.000919	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Vincristine—kidney cancer	0.000357	0.000915	CcSEcCtD
Hydroxocobalamin—Infection—Paclitaxel—kidney cancer	0.000356	0.000913	CcSEcCtD
Hydroxocobalamin—Dizziness—Sunitinib—kidney cancer	0.000353	0.000905	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Gemcitabine—kidney cancer	0.000353	0.000905	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Paclitaxel—kidney cancer	0.000352	0.000902	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—kidney cancer	0.000351	0.000901	CcSEcCtD
Hydroxocobalamin—Tachycardia—Paclitaxel—kidney cancer	0.00035	0.000897	CcSEcCtD
Hydroxocobalamin—Rash—Sorafenib—kidney cancer	0.00035	0.000897	CcSEcCtD
Hydroxocobalamin—Dermatitis—Sorafenib—kidney cancer	0.000349	0.000896	CcSEcCtD
Hydroxocobalamin—Skin disorder—Paclitaxel—kidney cancer	0.000348	0.000893	CcSEcCtD
Hydroxocobalamin—Headache—Sorafenib—kidney cancer	0.000347	0.000891	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Dactinomycin—kidney cancer	0.000346	0.000886	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Gemcitabine—kidney cancer	0.000338	0.000868	CcSEcCtD
Hydroxocobalamin—Rash—Sunitinib—kidney cancer	0.000336	0.000863	CcSEcCtD
Hydroxocobalamin—Dermatitis—Sunitinib—kidney cancer	0.000336	0.000862	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Capecitabine—kidney cancer	0.000334	0.000858	CcSEcCtD
Hydroxocobalamin—Headache—Sunitinib—kidney cancer	0.000334	0.000857	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—kidney cancer	0.000333	0.000855	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vincristine—kidney cancer	0.000333	0.000853	CcSEcCtD
Hydroxocobalamin—Nausea—Sorafenib—kidney cancer	0.000329	0.000845	CcSEcCtD
Hydroxocobalamin—Malaise—Capecitabine—kidney cancer	0.000325	0.000834	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Paclitaxel—kidney cancer	0.00032	0.00082	CcSEcCtD
Hydroxocobalamin—Rash—Dactinomycin—kidney cancer	0.000319	0.000817	CcSEcCtD
Hydroxocobalamin—Nausea—Sunitinib—kidney cancer	0.000317	0.000813	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Paclitaxel—kidney cancer	0.000316	0.000809	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000309	0.000794	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vincristine—kidney cancer	0.000309	0.000792	CcSEcCtD
Hydroxocobalamin—Chest pain—Capecitabine—kidney cancer	0.000307	0.000787	CcSEcCtD
Hydroxocobalamin—Pain—Paclitaxel—kidney cancer	0.000307	0.000786	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000305	0.000782	CcSEcCtD
Hydroxocobalamin—Discomfort—Capecitabine—kidney cancer	0.000303	0.000778	CcSEcCtD
Hydroxocobalamin—Pruritus—Gemcitabine—kidney cancer	0.000303	0.000777	CcSEcCtD
Hydroxocobalamin—Nausea—Dactinomycin—kidney cancer	0.0003	0.00077	CcSEcCtD
Hydroxocobalamin—Dizziness—Vincristine—kidney cancer	0.000298	0.000765	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Paclitaxel—kidney cancer	0.000295	0.000758	CcSEcCtD
Hydroxocobalamin—Oedema—Capecitabine—kidney cancer	0.000294	0.000754	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Gemcitabine—kidney cancer	0.000293	0.000751	CcSEcCtD
Hydroxocobalamin—Infection—Capecitabine—kidney cancer	0.000292	0.00075	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Capecitabine—kidney cancer	0.000289	0.00074	CcSEcCtD
Hydroxocobalamin—Tachycardia—Capecitabine—kidney cancer	0.000287	0.000736	CcSEcCtD
Hydroxocobalamin—Skin disorder—Capecitabine—kidney cancer	0.000286	0.000733	CcSEcCtD
Hydroxocobalamin—Urticaria—Paclitaxel—kidney cancer	0.000285	0.00073	CcSEcCtD
Hydroxocobalamin—Rash—Vincristine—kidney cancer	0.000285	0.00073	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vincristine—kidney cancer	0.000284	0.000729	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Paclitaxel—kidney cancer	0.000283	0.000727	CcSEcCtD
Hydroxocobalamin—Headache—Vincristine—kidney cancer	0.000283	0.000725	CcSEcCtD
Hydroxocobalamin—Rash—Gemcitabine—kidney cancer	0.00027	0.000692	CcSEcCtD
Hydroxocobalamin—Dermatitis—Gemcitabine—kidney cancer	0.00027	0.000692	CcSEcCtD
Hydroxocobalamin—Headache—Gemcitabine—kidney cancer	0.000268	0.000688	CcSEcCtD
Hydroxocobalamin—Nausea—Vincristine—kidney cancer	0.000268	0.000688	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Paclitaxel—kidney cancer	0.000264	0.000677	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000264	0.000676	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—kidney cancer	0.000263	0.000674	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Capecitabine—kidney cancer	0.000262	0.000673	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—kidney cancer	0.000262	0.000671	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Capecitabine—kidney cancer	0.000259	0.000664	CcSEcCtD
Hydroxocobalamin—Nausea—Gemcitabine—kidney cancer	0.000254	0.000652	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000254	0.000651	CcSEcCtD
Hydroxocobalamin—Pruritus—Paclitaxel—kidney cancer	0.000254	0.00065	CcSEcCtD
Hydroxocobalamin—Pain—Capecitabine—kidney cancer	0.000252	0.000645	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—kidney cancer	0.000249	0.00064	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—kidney cancer	0.000248	0.000635	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Paclitaxel—kidney cancer	0.000245	0.000629	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Capecitabine—kidney cancer	0.000242	0.000622	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—kidney cancer	0.000242	0.000621	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—kidney cancer	0.000241	0.000618	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—kidney cancer	0.000241	0.000617	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—kidney cancer	0.00024	0.000614	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—kidney cancer	0.000238	0.000612	CcSEcCtD
Hydroxocobalamin—Dizziness—Paclitaxel—kidney cancer	0.000237	0.000608	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—kidney cancer	0.000234	0.0006	CcSEcCtD
Hydroxocobalamin—Urticaria—Capecitabine—kidney cancer	0.000234	0.000599	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Capecitabine—kidney cancer	0.000233	0.000596	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—kidney cancer	0.000232	0.000596	CcSEcCtD
Hydroxocobalamin—Rash—Paclitaxel—kidney cancer	0.000226	0.00058	CcSEcCtD
Hydroxocobalamin—Dermatitis—Paclitaxel—kidney cancer	0.000226	0.000579	CcSEcCtD
Hydroxocobalamin—Headache—Paclitaxel—kidney cancer	0.000225	0.000576	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Capecitabine—kidney cancer	0.000217	0.000556	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000216	0.000553	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—kidney cancer	0.000214	0.000548	CcSEcCtD
Hydroxocobalamin—Nausea—Paclitaxel—kidney cancer	0.000213	0.000546	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—kidney cancer	0.00021	0.000537	CcSEcCtD
Hydroxocobalamin—Pruritus—Capecitabine—kidney cancer	0.000208	0.000534	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Capecitabine—kidney cancer	0.000201	0.000516	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—kidney cancer	0.000198	0.000507	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000196	0.000504	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—kidney cancer	0.000195	0.000501	CcSEcCtD
Hydroxocobalamin—Dizziness—Capecitabine—kidney cancer	0.000195	0.000499	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—kidney cancer	0.00019	0.000486	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—kidney cancer	0.00019	0.000486	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—kidney cancer	0.000188	0.000483	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—kidney cancer	0.000186	0.000477	CcSEcCtD
Hydroxocobalamin—Rash—Capecitabine—kidney cancer	0.000185	0.000476	CcSEcCtD
Hydroxocobalamin—Dermatitis—Capecitabine—kidney cancer	0.000185	0.000475	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—kidney cancer	0.000185	0.000475	CcSEcCtD
Hydroxocobalamin—Headache—Capecitabine—kidney cancer	0.000184	0.000473	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—kidney cancer	0.000184	0.000472	CcSEcCtD
Hydroxocobalamin—Nausea—Capecitabine—kidney cancer	0.000175	0.000448	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—kidney cancer	0.000169	0.000434	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—kidney cancer	0.000167	0.000428	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000164	0.00042	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—kidney cancer	0.000162	0.000416	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—kidney cancer	0.000156	0.000401	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—kidney cancer	0.000151	0.000386	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—kidney cancer	0.00015	0.000384	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—kidney cancer	0.00014	0.000358	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—kidney cancer	0.000134	0.000344	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—kidney cancer	0.00013	0.000333	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—kidney cancer	0.000125	0.000322	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—kidney cancer	0.00012	0.000307	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—kidney cancer	0.000119	0.000306	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—kidney cancer	0.000119	0.000305	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—kidney cancer	0.000113	0.000289	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—EGR1—kidney cancer	5.65e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SLC2A1—kidney cancer	5.62e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—MAPK1—kidney cancer	5.61e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—ERBB2—kidney cancer	5.6e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ERBB2—kidney cancer	5.6e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GRB7—kidney cancer	5.59e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—JUNB—kidney cancer	5.58e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.57e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CYP1A1—kidney cancer	5.57e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—kidney cancer	5.53e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—kidney cancer	5.53e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MTOR—kidney cancer	5.52e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MTOR—kidney cancer	5.52e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CD4—kidney cancer	5.51e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CD4—kidney cancer	5.51e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CTNNB1—kidney cancer	5.49e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNA2—kidney cancer	5.49e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—POMC—kidney cancer	5.48e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—kidney cancer	5.47e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—kidney cancer	5.47e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—RAF1—kidney cancer	5.4e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MAPK3—kidney cancer	5.38e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTEN—kidney cancer	5.35e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ERBB2—kidney cancer	5.34e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KRAS—kidney cancer	5.3e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTEN—kidney cancer	5.27e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MTOR—kidney cancer	5.27e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CD4—kidney cancer	5.26e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDH1—kidney cancer	5.26e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MYC—kidney cancer	5.23e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—kidney cancer	5.22e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSTP1—kidney cancer	5.21e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KIT—kidney cancer	5.21e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—APC—kidney cancer	5.21e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ITPR2—kidney cancer	5.19e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CDKN1B—kidney cancer	5.18e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CDKN1B—kidney cancer	5.18e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—kidney cancer	5.14e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MAPK1—kidney cancer	5.12e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—POMC—kidney cancer	5.06e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—RAF1—kidney cancer	4.98e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CDKN1B—kidney cancer	4.94e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ABCB1—kidney cancer	4.94e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ERBB2—kidney cancer	4.93e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MAPK3—kidney cancer	4.92e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MAPK3—kidney cancer	4.92e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—BRAF—kidney cancer	4.9e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CTNNB1—kidney cancer	4.9e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CTNNB1—kidney cancer	4.9e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—PIK3CA—kidney cancer	4.87e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MTOR—kidney cancer	4.86e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CD4—kidney cancer	4.85e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KRAS—kidney cancer	4.84e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTEN—kidney cancer	4.82e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTEN—kidney cancer	4.82e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HIF1A—kidney cancer	4.82e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—kidney cancer	4.82e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TSC2—kidney cancer	4.81e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSTM1—kidney cancer	4.79e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MYC—kidney cancer	4.79e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MYC—kidney cancer	4.79e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTEN—kidney cancer	4.77e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTEN—kidney cancer	4.77e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNA1—kidney cancer	4.71e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MAPK1—kidney cancer	4.68e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MAPK1—kidney cancer	4.68e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EIF4EBP1—kidney cancer	4.68e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HSPB1—kidney cancer	4.68e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CTNNB1—kidney cancer	4.67e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—RAF1—kidney cancer	4.67e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—RELA—kidney cancer	4.65e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—ERBB2—kidney cancer	4.62e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD8A—kidney cancer	4.61e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—kidney cancer	4.58e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—kidney cancer	4.58e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MAPK3—kidney cancer	4.57e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CDKN1B—kidney cancer	4.56e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MTOR—kidney cancer	4.56e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTEN—kidney cancer	4.55e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CD4—kidney cancer	4.55e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP1A1—kidney cancer	4.54e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN2B—kidney cancer	4.54e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTEN—kidney cancer	4.48e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—RAF1—kidney cancer	4.48e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—RELA—kidney cancer	4.46e-05	0.000117	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MYC—kidney cancer	4.45e-05	0.000117	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PIK3CA—kidney cancer	4.44e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERBB2—kidney cancer	4.43e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—kidney cancer	4.42e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—kidney cancer	4.42e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—MTOR—kidney cancer	4.38e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—kidney cancer	4.37e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD4—kidney cancer	4.37e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MAPK1—kidney cancer	4.35e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TSC1—kidney cancer	4.35e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PSMD7—kidney cancer	4.35e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ANXA1—kidney cancer	4.35e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CTNNB1—kidney cancer	4.31e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CDKN1B—kidney cancer	4.28e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KIT—kidney cancer	4.25e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APC—kidney cancer	4.25e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FLT1—kidney cancer	4.21e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTEN—kidney cancer	4.2e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—POMC—kidney cancer	4.15e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—kidney cancer	4.11e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDKN1B—kidney cancer	4.11e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—RAF1—kidney cancer	4.09e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MAPK3—kidney cancer	4.08e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MAPK3—kidney cancer	4.08e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—JUN—kidney cancer	4.07e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PIK3CA—kidney cancer	4.06e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PIK3CA—kidney cancer	4.06e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERBB2—kidney cancer	4.05e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CTNNB1—kidney cancer	4.04e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—kidney cancer	4.03e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTEN—kidney cancer	4e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTEN—kidney cancer	4e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MTOR—kidney cancer	3.99e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—BRAF—kidney cancer	3.99e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CD4—kidney cancer	3.99e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MYC—kidney cancer	3.97e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MYC—kidney cancer	3.97e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—kidney cancer	3.96e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PTEN—kidney cancer	3.94e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TSC2—kidney cancer	3.92e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUNB—kidney cancer	3.91e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PAK1—kidney cancer	3.91e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MAPK3—kidney cancer	3.89e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MAPK1—kidney cancer	3.88e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MAPK1—kidney cancer	3.88e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTEN—kidney cancer	3.81e-05	0.0001	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—kidney cancer	3.78e-05	9.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTEN—kidney cancer	3.78e-05	9.91e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PIK3CA—kidney cancer	3.78e-05	9.9e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1B—kidney cancer	3.75e-05	9.82e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PIK3CA—kidney cancer	3.72e-05	9.75e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MAPK1—kidney cancer	3.7e-05	9.7e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—kidney cancer	3.66e-05	9.61e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—kidney cancer	3.66e-05	9.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HIF1A—kidney cancer	3.63e-05	9.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TSC2—kidney cancer	3.62e-05	9.49e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAPK3—kidney cancer	3.59e-05	9.41e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—kidney cancer	3.54e-05	9.28e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—kidney cancer	3.52e-05	9.22e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—kidney cancer	3.5e-05	9.16e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—kidney cancer	3.49e-05	9.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIT—kidney cancer	3.46e-05	9.08e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—kidney cancer	3.45e-05	9.05e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAPK1—kidney cancer	3.42e-05	8.96e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—kidney cancer	3.4e-05	8.92e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—kidney cancer	3.4e-05	8.92e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—POMC—kidney cancer	3.39e-05	8.88e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—kidney cancer	3.37e-05	8.83e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—kidney cancer	3.37e-05	8.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK3—kidney cancer	3.36e-05	8.82e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—RAF1—kidney cancer	3.33e-05	8.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—kidney cancer	3.31e-05	8.69e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—kidney cancer	3.3e-05	8.65e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTOR—kidney cancer	3.26e-05	8.53e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CD4—kidney cancer	3.25e-05	8.52e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—kidney cancer	3.23e-05	8.46e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—kidney cancer	3.23e-05	8.46e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—kidney cancer	3.21e-05	8.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK1—kidney cancer	3.2e-05	8.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APC—kidney cancer	3.2e-05	8.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KIT—kidney cancer	3.2e-05	8.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF2—kidney cancer	3.19e-05	8.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDH1—kidney cancer	3.19e-05	8.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN2B—kidney cancer	3.18e-05	8.34e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—kidney cancer	3.16e-05	8.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1R—kidney cancer	3.09e-05	8.1e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1B—kidney cancer	3.05e-05	8.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—kidney cancer	3.02e-05	7.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BRAF—kidney cancer	3.01e-05	7.88e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—kidney cancer	2.96e-05	7.77e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAPK3—kidney cancer	2.95e-05	7.73e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—kidney cancer	2.9e-05	7.61e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—kidney cancer	2.89e-05	7.58e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—kidney cancer	2.89e-05	7.57e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—kidney cancer	2.87e-05	7.52e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—kidney cancer	2.82e-05	7.39e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—kidney cancer	2.82e-05	7.39e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—kidney cancer	2.81e-05	7.37e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAPK1—kidney cancer	2.81e-05	7.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—kidney cancer	2.78e-05	7.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RAF1—kidney cancer	2.72e-05	7.13e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RELA—kidney cancer	2.71e-05	7.1e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—kidney cancer	2.7e-05	7.08e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—kidney cancer	2.69e-05	7.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—kidney cancer	2.69e-05	7.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—kidney cancer	2.67e-05	6.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MTOR—kidney cancer	2.65e-05	6.96e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—kidney cancer	2.65e-05	6.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD4—kidney cancer	2.65e-05	6.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIF1A—kidney cancer	2.54e-05	6.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TSC2—kidney cancer	2.54e-05	6.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—RAF1—kidney cancer	2.51e-05	6.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1B—kidney cancer	2.49e-05	6.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—kidney cancer	2.48e-05	6.51e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—kidney cancer	2.48e-05	6.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTOR—kidney cancer	2.45e-05	6.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD4—kidney cancer	2.45e-05	6.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—kidney cancer	2.44e-05	6.39e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—kidney cancer	2.43e-05	6.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—kidney cancer	2.43e-05	6.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—kidney cancer	2.43e-05	6.37e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAPK3—kidney cancer	2.4e-05	6.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JUN—kidney cancer	2.37e-05	6.22e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—kidney cancer	2.36e-05	6.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—kidney cancer	2.35e-05	6.17e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—kidney cancer	2.34e-05	6.13e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1B—kidney cancer	2.3e-05	6.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—kidney cancer	2.29e-05	6.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAPK1—kidney cancer	2.29e-05	5.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APC—kidney cancer	2.24e-05	5.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KIT—kidney cancer	2.24e-05	5.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—kidney cancer	2.17e-05	5.7e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—kidney cancer	2.16e-05	5.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—POMC—kidney cancer	2.13e-05	5.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—kidney cancer	2.12e-05	5.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BRAF—kidney cancer	2.11e-05	5.52e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—kidney cancer	2.04e-05	5.34e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—kidney cancer	1.98e-05	5.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK3—kidney cancer	1.96e-05	5.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK1—kidney cancer	1.86e-05	4.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAPK3—kidney cancer	1.81e-05	4.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—kidney cancer	1.76e-05	4.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—kidney cancer	1.76e-05	4.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RAF1—kidney cancer	1.76e-05	4.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RELA—kidney cancer	1.75e-05	4.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—kidney cancer	1.74e-05	4.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAPK1—kidney cancer	1.72e-05	4.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MTOR—kidney cancer	1.72e-05	4.5e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—kidney cancer	1.66e-05	4.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—kidney cancer	1.63e-05	4.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—kidney cancer	1.62e-05	4.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1B—kidney cancer	1.61e-05	4.22e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—kidney cancer	1.58e-05	4.13e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—kidney cancer	1.54e-05	4.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUN—kidney cancer	1.53e-05	4.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—kidney cancer	1.52e-05	3.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—kidney cancer	1.49e-05	3.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—kidney cancer	1.48e-05	3.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—kidney cancer	1.34e-05	3.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK3—kidney cancer	1.27e-05	3.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—kidney cancer	1.23e-05	3.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK1—kidney cancer	1.21e-05	3.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—kidney cancer	1.14e-05	2.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—kidney cancer	1.05e-05	2.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—kidney cancer	1.01e-05	2.65e-05	CbGpPWpGaD
